196 related articles for article (PubMed ID: 31600969)
21. Bioavailability of Orally Delivered Alpha-Tocopherol by Poly(Lactic-Co-Glycolic) Acid (PLGA) Nanoparticles and Chitosan Covered PLGA Nanoparticles in F344 Rats.
Simon LC; Stout RW; Sabliov C
Nanobiomedicine (Rij); 2016; 3():8. PubMed ID: 29942383
[TBL] [Abstract][Full Text] [Related]
22. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay.
Öztürk AA; Kıyan HT
Microvasc Res; 2020 Mar; 128():103961. PubMed ID: 31758946
[TBL] [Abstract][Full Text] [Related]
23. Chitosan-Coated PLGA Nanoparticles Encapsulating Triamcinolone Acetonide as a Potential Candidate for Sustained Ocular Drug Delivery.
Dandamudi M; McLoughlin P; Behl G; Rani S; Coffey L; Chauhan A; Kent D; Fitzhenry L
Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683883
[TBL] [Abstract][Full Text] [Related]
24. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
25. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
Yang Y; Xie XY; Mei XG
Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
[TBL] [Abstract][Full Text] [Related]
26. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa].
Wang JT; Lin DH; Qin LF; Wen Z; Guo GP
Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701
[TBL] [Abstract][Full Text] [Related]
27. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA
Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421
[TBL] [Abstract][Full Text] [Related]
28. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
29. Improved oral delivery of insulin by PLGA nanoparticles coated with 5
Wang W; Yu C; Zhang F; Li Y; Zhang B; Huang J; Zhang Z; Jin L
Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34571498
[TBL] [Abstract][Full Text] [Related]
30. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
[TBL] [Abstract][Full Text] [Related]
31. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
[TBL] [Abstract][Full Text] [Related]
32. A Chitosan-PLGA based catechin hydrate nanoparticles used in targeting of lungs and cancer treatment.
Ahmad N; Ahmad R; Alrasheed RA; Almatar HMA; Al-Ramadan AS; Buheazah TM; AlHomoud HS; Al-Nasif HA; Alam MA
Saudi J Biol Sci; 2020 Sep; 27(9):2344-2357. PubMed ID: 32884416
[TBL] [Abstract][Full Text] [Related]
33. Coating of chitosan on poly D,L-lactic-co-glycolic acid thymoquinone nanoparticles enhances the anti-tumor activity in triple-negative breast cancer.
Gao J; Kumari A; Zeng XA; Chan S; Farooq MA; Alee M; Khan SH; Rahaman A; He S; Xin X; Mehmood T
Front Chem; 2023; 11():1044953. PubMed ID: 36846852
[TBL] [Abstract][Full Text] [Related]
34. [Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly (lactic-co-glycolic acid) nanoparticles].
Pan Y; Li YJ; Gao P; Ding PT; Xu H; Zheng JM
Yao Xue Xue Bao; 2003 Jun; 38(6):467-70. PubMed ID: 14513811
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
36. Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity.
Haggag YA; Abosalha AK; Tambuwala MM; Osman EY; El-Gizawy SA; Essa EA; Donia AA
Biopharm Drug Dispos; 2021 Jan; 42(1):12-23. PubMed ID: 33320969
[TBL] [Abstract][Full Text] [Related]
37. Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design.
Salem HF; Ali AA; Rabea YK; Abo El-Ela FI; Khallaf RA
J Pharm Sci; 2023 Feb; 112(2):544-561. PubMed ID: 36063878
[TBL] [Abstract][Full Text] [Related]
38. Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design,
Ameeduzzafar ; Khan N; Alruwaili NK; Bukhari SNA; Alsuwayt B; Afzal M; Akhter S; Yasir M; Elmowafy M; Shalaby K; Ali A
Iran J Pharm Res; 2020; 19(1):292-311. PubMed ID: 32922488
[TBL] [Abstract][Full Text] [Related]
39. Comparison of immune responses in guinea pigs by intranasal delivery with different nanoparticles-loaded FMDV DNA vaccine.
Zheng H; Pan L; Lv J; Zhang Z; Wang Y; Hu W; Liu X; Zhou P; Wang Y; Zhang Y
Microb Pathog; 2020 Feb; 142():104061. PubMed ID: 32061916
[TBL] [Abstract][Full Text] [Related]
40. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]